(Date:11/10/2009)... iSirona Appoints John Cooper as Chairma...ity, Fla. (PRWEB) November 10, 2009 -- iSirona®...ions for healthcare providers, today announced the...rd, effective October 21, 2009. He replaces Chairm...e to serve as the company,s CEO and retains a seat...
(Date:11/9/2009)...N, Nov. 9 The Appignani...ist Association, held a panel discussion today at ...merging technologies in biomedical sciences and cl...oreno and Andrew Light, both of the Center for Ame...ical and political angles. ,, A video of the e...
(Date:11/9/2009)..., Nov. 9 BioMed Realty T...company has received commitments from lenders to i...ne of credit by $65 million to an aggregate of $66...he facility. The weighted-average effective inter... as of September 30, 2009. The maturity date remai...
(Date:11/9/2009)..., Nov. 9 NexBio, Inc. announced th...ican College of Allergy, Asthma, and Immunology in...AS181 (Fludase®), a Sialidase, Decreases Airw...ects in Animal Models of Asthma". ,, DAS181 (Fl...m host-targeting drug candidate being studied in h...
Breaking Biology Technology:iSirona Selects New Chairman of the Board 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 3BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 2BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 3NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3